Biological activities of synthetic oligosaccharides and glycolipids from mycobacteria

Journal of Carbohydrate Chemistry

Volumn 30, Issue 7-9, 2011, Pages 415-437

  Hutacharoen, Panatpong ^a,b   Ruchirawat, Somsak ^b,c   Boonyarattanakalin, Siwarutt ^a  

^a THAMMASAT UNIVERSITY   (Thailand)

^b Research and Innovation   (Thailand)

^c Toxicology and Management of Chemicals   (Thailand)

Author keywords

Glycolipid; Lipoglycan; Mycobacteria; Mycobacterium tuberculosis (Mtb); Synthetic oligosaccharide

Indexed keywords

CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 84856315361     PISSN: 07328303     EISSN: 15322327     Source Type: Journal    
DOI: 10.1080/07328303.2011.621041     Document Type: Article

References (111)

1. Borgdorff, M.W.; Floyd, K.; Broekmans, J.F. Interventions to reduce tuberculosismortality and transmission in low- and middle-income countries. Bull. World Health Organ. 2002, 80, 217-227. (Pubitemid 34285734)
2. Kaufmann, S.H. Envisioning future strategies for vaccination against tuberculosis. Nat. Rev. Immunol. 2006, 6, 699-704. (Pubitemid 44298219)
3. Kaufmann, S.H. The contribution of immunology to the rational design of novel antibacterial vaccines. Nat. Rev. Microbiol. 2007, 5, 491-504. (Pubitemid 46925378)
4. Ortalo-Magne, A.; Lemassu, A.; Laneelle, M.A.; Bardou, F.; Silve, G.; Gounon, P.; Marchal, G.; Daffe, M. Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species. J. Bacteriol. 1996, 178, 456-461. (Pubitemid 26030599)
5. Neyrolles, O.; Guilhot, C. Recent advances in deciphering the contribution of Mycobacterium tuberculosis lipids to pathogenesis. Tuberculosis (Edinb.) 2011, 91, 187-195.
6. Quesniaux, V.J.; Nicolle, D.M.; Torres, D.; Kremer, L.; Guerardel, Y.; Nigou, J.; Puzo, G.; Erard, F.; Ryffel, B. Toll-like receptor 2 (TLR2)-dependent-positive and TLR2- independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. J. Immunol. 2004, 172, 4425-4434. (Pubitemid 38375258)
7. Werz, D.B.; Seeberger, P.H. Carbohydrates as the next frontier in pharmaceutical research. Chem. Eur. J. 2005, 11, 3194-3206. (Pubitemid 40750980)
8. Hecht, M.L.; Stallforth, P.; Silva, D.V.; Adibekian, A.; Seeberger, P.H. Recent advances in carbohydrate-based vaccines. Curr. Opin. Chem. Biol. 2009, 13, 354-359.
9. Roy, R. New trends in carbohydrate-based vaccines. Drug Discov. Today Technol. 2004, 1, 327-336. (Pubitemid 40197583)
10. Verez-Bencomo, V.; Fernandez-Santana, V.; Hardy, E.; Toledo, M.E.; Rodriguez, M.C.; Heynngnezz, L.; Rodriguez, A.; Baly, A.; Herrera, L.; Izquierdo, M.; Villar, A.; Valdes, Y.; Cosme, K.; Deler, M.L.; Montane, M.; Garcia, E.; Ramos, A.; Aguilar, A.; Medina, E.; Torano, G.; Sosa, I.; Hernandez, I.; Martinez, R.; Muzachio, A.; Carmenates, A.; Costa, L.; Cardoso, F.; Campa, C.; Diaz, M.; Roy, R. A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b. Science 2004, 305, 522-525. (Pubitemid 38971343)
11. Danishefsky, S.J.; Allen, J.R. From the laboratory to the clinic: A retrospective on fully synthetic carbohydrate-based anticancer vaccines. Angew. Chem. Int. Ed. 2000, 39, 836-863. (Pubitemid 30217267)
12. Pan, Y.; Chefalo, P.; Nagy, N.; Harding, C.; Guo, Z. Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines. J. Med. Chem. 2005, 48, 875-883. (Pubitemid 40209110)
13. Schofield, L.; Hewitt, M.C.; Evans, K.; Siomos, M.A.; Seeberger, P.H. Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature 2002, 418, 785-789.
14. Werz, D.B.; Seeberger, P.H. Total synthesis of antigen bacillus anthracis tetrasaccharide-creation of an anthrax vaccine candidate. Angew. Chem. Int. Ed. 2005, 44, 6315-6318. (Pubitemid 41454652)
15. Tamborrini, M.; Werz, D.B.; Frey, J.; Pluschke, G.; Seeberger, P.H. Anticarbohydrate antibodies for the detection of anthrax spores. Angew. Chem. Int. Ed. 2006, 45, 6581-6582. (Pubitemid 44563630)
16. Kallenius, G.; Pawlowski, A.; Hamasur, B.; Svenson, S.B. Mycobacterial glycoconjugates as vaccine candidates against tuberculosis. Trends Microbiol. 2008, 16, 456-462.
17. Nigou, J.; Gilleron, M.; Cahuzac, B.; Bounery, J.D.; Herold, M.; Thurnher, M.; Puzo, G. The phosphatidyl-myo-inositol anchor of the lipoarabinomannans from Mycobacterium bovis bacillus Calmette Guerin. Heterogeneity, structure, and role in the regulation of cytokine secretion. J. Biol. Chem. 1997, 272, 23094-23103. (Pubitemid 27392437)
18. Daffe, M.; Draper, P. The envelope layers of mycobacteria with reference to their pathogenicity. Adv. Microb. Physiol. 1998, 39, 131-203. (Pubitemid 29077883)
19. Zuber, B.; Chami, M.; Houssin, C.; Dubochet, J.; Griffiths, G.; Daffe, M. Direct visualization of the outer membrane of mycobacteria and corynebacteria in their native state. J. Bacteriol. 2008, 190, 5672-5680.
20. Jackson, M.; Stadthagen, G.; Gicquel, B. Long-chain multiple methyl-branched fatty acid-containing lipids of Mycobacterium tuberculosis: biosynthesis, transport, regulation and biological activities. Tuberculosis (Edinb.) 2007, 87, 78-86. (Pubitemid 46217257)
21. Umesiri, F.E.; Sanki, A.K.; Boucau, J.; Ronning, D.R.; Sucheck, S.J. Recent advances toward the inhibition of mAG and LAM synthesis in Mycobacterium tuberculosis. Med. Res. Rev. 2010, 30, 290-326.
22. Minnikin, D.E. Chemical principles in the organization of lipid components in the mycobacterial cell envelope. Res. Microbiol. 1991, 142, 423-427.
23. Astarie-Dequeker, C.; Nigou, J.; Passemar, C.; Guilhot, C. The role of mycobacterial lipids in host pathogenesis. Drug Discov. Today Dis. Mech. 2010, 7, e33-e41.
24. Daffe,M.; Lacave, C.; Laneelle,M.A.; Laneelle, G. Structure of the major triglycosyl phenol-phthiocerol of Mycobacterium tuberculosis (strain Canetti). Eur. J. Biochem. 1987, 167, 155-160. (Pubitemid 17128396)
25. Malaga, W.; Constant, P.; Euphrasie, D.; Cataldi, A.; Daffe, M.; Reyrat, J.M.; Guilhot, C. Deciphering the genetic bases of the structural diversity of phenolic glycolipids in strains of the Mycobacterium tuberculosis complex. J. Biol. Chem. 2008, 283, 15177-15184.
26. Besra, G.S.; Bolton, R.C.; McNeil, M.R.; Ridell, M.; Simpson, K.E.; Glushka, J.; van Halbeek, H.; Brennan, P.J.; Minnikin, D.E. Structural elucidation of a novel family of acyltrehaloses from Mycobacterium tuberculosis. Biochemistry 1992, 31, 9832-9837.
27. Minnikin, D.E.; Dobson, G.; Sesardic, D.; Ridell, M. Mycolipenates and mycolipanolates of trehalose from mycobacterium tuberculosis. J. Gen. Microbiol. 1985, 131, 1369-1374. (Pubitemid 15013638)
28. Matsunaga, I.; Bhatt, A.; Young, D.C.; Cheng, T.Y.; Eyles, S.J.; Besra, G.S.; Briken, V.; Porcelli, S.A.; Costello, C.E.; Jacobs, W.R., Jr.; Moody, D.B. Mycobacterium tuberculosis pks12 produces a novel polyketide presented by CD1c to T cells. J. Exp. Med. 2004, 200, 1559-1569. (Pubitemid 40094180)
29. Moody, D.B.; Ulrichs, T.; Muhlecker, W.; Young, D.C.; Gurcha, S.S.; Grant, E.; Rosat, J.P.; Brenner, M.B.; Costello, C.E.; Besra, G.S.; Porcelli, S.A. CD1c-mediated Tcell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature 2000, 404, 884-888. (Pubitemid 30230341)
30. Schorey, J.S.; Sweet, L. The mycobacterial glycopeptidolipids: Structure, function, and their role in pathogenesis. Glycobiology 2008, 18, 832-841.
31. Pitarque, S.; Larrouy-Maumus, G.; Payŕe, B.; Jackson, M.; Puzo, G.; Nigou, J. The immunomodulatory lipoglycans, lipoarabinomannan and lipomannan, are exposed at the mycobacterial cell surface. Tuberculosis 2008, 88, 560-565.
32. Marrakchi, H.; Bardou, F.; Laneelle,M.A.; Daffe,M. A comprehensive overview of mycolic acid structure and biosynthesis. In The Mycobacterial Cell Envelope; M. Daffe, J. M. Reyrat (Eds.); ASM Press: Washington, DC, 2008; 41-62.
33. Barry 3rd, C.E.; Lee, R.E.; Mdluli, K.; Sampson, A.E.; Schroeder, B.G.; Slayden, R.A.; Yuan, Y. Mycolic acids: Structure, biosynthesis and physiological functions. Prog. Lipid Res. 1998, 37, 143-179. (Pubitemid 28391410)
34. Brennan, P.J. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis (Edinb.) 2003, 83, 91-97. (Pubitemid 36683556)
35. Hoffmann, C.; Leis, A.; Niederweis, M.; Plitzko, J.M.; Engelhardt, H. Disclosure of the mycobacterial outer membrane: Cryo-electron tomography and vitreous sections reveal the lipid bilayer structure. Proc. Natl. Acad. Sci. U S A 2008, 105, 3963-3967. (Pubitemid 351723507)
36. Koester, D.C.; Awan, S.I.;Werz, D.B. Hot on the trail of trehalose: A carbohydratebased method for imaging Mycobacterium tuberculosis. Chembiochem. 2011, 12, 1975-1977.
37. Domenech, P.; Reed, M.B. Rapid and spontaneous loss of phthiocerol dimycocerosate (PDIM) from Mycobacterium tuberculosis grown in vitro: Implications for virulence studies. Microbiology 2009, 155, 3532-3543.
38. Constant, P.; Perez, E.; Malaga, W.; Laneelle, M.A.; Saurel, O.; Daffe, M.; Guilhot, C. Role of the pks15/1 gene in the biosynthesis of phenolglycolipids in the Mycobacterium tuberculosis complex. Evidence that all strains synthesize glycosylated phydroxybenzoic methyl esters and that strains devoid of phenolglycolipids harbor a frameshift mutation in the pks15/1 gene. J. Biol. Chem. 2002, 277, 38148-38158. (Pubitemid 35154668)
39. Gonzalo Asensio, J.; Maia, C.; Ferrer, N.L.; Barilone, N.; Laval, F.; Soto, C.Y.; Winter, N.; Daffe,M.; Gicquel, B.;Martin, C.; Jackson,M. The virulence-associated twocomponent PhoP-PhoR system controls the biosynthesis of polyketide-derived lipids in Mycobacterium tuberculosis. J. Biol. Chem. 2006, 281, 1313-1316.
40. Daffe, M.; Lacave, C.; Laneelle, M.A.; Gillois, M.; Laneelle, G. Polyphthienoyl trehalose, glycolipids specific for virulent strains of the tubercle bacillus. Eur. J. Biochem. 1988, 172, 579-584. (Pubitemid 18076476)
41. Cason, J.; Allen, C.F.; Deacetis, W.; Fonken, G.J. Fatty acids from the lipids of non-virulent strains of the tubercle bacillus. J. Biol. Chem. 1956, 220, 893-904.
42. Camacho, L.R.; Constant, P.; Raynaud, C.; Laneelle, M.A.; Triccas, J.A.; Gicquel, B.; Daffe, M.; Guilhot, C. Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier. J. Biol. Chem. 2001, 276, 19845-19854.
43. Glickman, M.S.; Cox, J.S.; Jacobs Jr, W.R. A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Mol. Cell 2000, 5, 717-727.
44. Tenu, J.P.; Lederer, E.; Petit, J.F. Stimulation of thymocyte mitogenic protein secretion and of cytostatic activity of mouse peritoneal macrophages by trehalose dimycolate and muramyldipeptide. Eur. J. Immunol. 1980, 10, 647-653. (Pubitemid 10034596)
45. Bekierkunst, A. Acute granulomatous response produced in mice by trehalose- 6,6-dimycolate. J. Bacteriol. 1968, 96, 958-961.
46. Sakurai, T.; Saiki, I.; Ishida, H.; Takeda, K.; Azuma, I. Lethal toxicity and adjuvant activities of synthetic TDM and its related compounds in mice. Vaccine 1989, 7, 269-274. (Pubitemid 19174466)
47. Saito, R.; Tanaka, A.; Sugiyama, K. Adjuvant effect of cord factor, a mycobacterial lipid. Infect. Immun. 1976, 13, 776-781.
48. Numata, F.; Nishimura, K.; Ishida, H. Lethal and adjuvant activities of cord factor (trehalose-6,6'-dimycolate) and synthetic analogs in mice. Chem. Pharm. Bull. 1985, 33, 4544-4555. (Pubitemid 16205703)
49. Yarkoni, E.; Bekierkunst, A. Nonspecific resistance against infection with Salmonella typhi and Salmonella typhimurium induced in mice by cord factor (trehalose 6,6 dimycolate) and its analogues. Infect. Immun. 1976, 14, 1125-1129.
50. Parant, M.; Audibert, F.; Parant, F. Nonspecific immunostimulant activities of synthetic trehalose-6,6'-diesters (lower homologs of cord factor). Infect. Immun. 1978, 20, 12-19. (Pubitemid 8315781)
51. Bekierkunst, A.; Levij, I.S.; Yarkoni, E.; Vilkas, E.; Lederer, E. Suppression of urethan-induced lung adenomas in mice treated with trehalose-6,6-dimycolate (cord factor) and living bacillus Calmette Gúerin. Science 1971, 174, 1240-1242.
52. Orbach Arbouys, S.; Tenu, J.P.; Petit, J.F. Enhancement of in vitro and in vivo antitumor activity by cord factor (6-6-dimycolate of trehalose) administered suspended in saline. Int. Arch. Allergy Immunol. 1983, 71, 67-73.
53. Toubiana, R.; Ribi, E.; McLaughlin, C.; Strain, S.M. The effect of synthetic and naturally occurring trehalose fatty acid esters in tumor regression. Cancer Immunol. Immunother. 1977, 2, 189-193. (Pubitemid 8185259)
54. Watanabe, R.; Yoo, Y.C.; Hata, K.; Mitobe, M.; Koike, Y.; Nishizawa, M.; Garcia, D.M.; Nobuchi, Y.; Imagawa, H.; Yamada, H.; Azuma, I. Inhibitory effect of trehalose dimycolate (TDM) and its stereoisometric derivatives, trehalose dicorynomycolates(TDCMs), with low toxicity on lung metastasis of tumour cells in mice. Vaccine 1999, 17, 1484-1492. (Pubitemid 29138816)
55. Azuma, I. Synthetic immunoadjuvants: Application to non-specific host stimulation and potentiation of vaccine immunogenicity. Vaccine 1992, 10, 1000-1006.
56. Nishizawa, M.; Yamamoto, H.; Imagawa, H.; Barbier-Chassefiere, V.; Petit, E.; Azuma, I.; Papy-Garcia, D. Efficient syntheses of a series of trehalose dimycolate (TDM)/trehalose dicorynomycolate (TDCM) analogues and their interleukin-6 level enhancement activity in mice sera. J. Org. Chem. 2007, 72, 1627-1633. (Pubitemid 46355458)
57. Werninghaus, K.; Babiak, A.; Gross, O.; Holscher, C.; Dietrich, H.; Agger, E.M.; Mages, J.; Mocsai, A.; Schoenen, H.; Finger, K.; Nimmerjahn, F.; Brown, G.D.; Kirschning, C.; Heit, A.; Andersen, P.; Wagner, H.; Ruland, J.; Lang, R. Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRgamma-Syk-Card9-dependent innate immune activation. J. Exp. Med. 2009, 206, 89-97.
58. Doz, E.; Rose, S.; Court, N.; Front, S.; Vasseur, V.; Charron, S.; Gilleron, M.; Puzo, G.; Fremaux, I.; Delneste, Y.; Erard, F.; Ryffel, B.; Martin, O.R.; Quesniaux, V.F. Mycobacterial phosphatidylinositol mannosides negatively regulate host Toll-like receptor 4, MyD88-dependent proinflammatory cytokines, and TRIF-dependent co-stimulatory molecule expression. J. Biol. Chem. 2009, 284, 23187-23196.
59. Guiard, J.; Collmann, A.; Garcia-Alles, L.F.; Mourey, L.; Brando, T.; Mori, L.; Gilleron, M.; Prandi, J.; De Libero, G.; Puzo, G. Fatty acyl structures of mycobacterium tuberculosis sulfoglycolipid govern T cell response. J. Immunol. 2009, 182, 7030-7037.
60. de Jong, A.; Arce, E.C.; Cheng, T.Y.; van Summeren, R.P.; Feringa, B.L.; Dudkin, V.; Crich, D.; Matsunaga, I.; Minnaard, A.J.; Moody, D.B. CD1c presentation of synthetic glycolipid antigens with foreign alkyl branching motifs. Chem. Biol. 2007, 14, 1232-1242. (Pubitemid 350102239)
61. Koppel, E.A.; Ludwig, I.S.; Hernandez, M.S.; Lowary, T.L.; Gadikota, R.R.; Tuzikov, A.B.; Vandenbroucke-Grauls, C.M.; van Kooyk, Y.; Appelmelk, B.J.; Geijtenbeek, T.B. Identification of the mycobacterial carbohydrate structure that binds the C-type lectins DC-SIGN, L-SIGN and SIGNR1. Immunobiology 2004, 209, 117-127. (Pubitemid 39255697)
62. Schoenen, H.; Bodendorfer, B.; Hitchens, K.; Manzanero, S.; Werninghaus, K.; Nimmerjahn, F.; Agger, E.M.; Stenger, S.; Andersen, P.; Ruland, J.; Brown, G.D.; Wells, C.; Lang, R. Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate. J. Immunol. 2010, 184, 2756-2760.
63. Stadelmaier, A.; Schmidt, R.R. Synthesis of phosphatidylinositol mannosides (PIMs). Carbohydr. Res. 2003, 338, 2557-2569.
64. Boonyarattanakalin, S.; Liu, X.; Michieletti, M.; Lepenies, B.; Seeberger, P.H. Chemical synthesis of all phosphatidylinositol mannoside (PIM) glycans from Mycobacterium tuberculosis. J. Am. Chem. Soc. 2008, 130, 16791-16799.
65. Dyer, B.S.; Jones, J.D.; Ainge, G.D.; Denis, M.; Larsen, D.S.; Painter, G.F. Synthesis and structure of phosphatidylinositol dimannoside. J. Org. Chem. 2007, 72, 3282-3288. (Pubitemid 46668129)
66. Liu, X.; Stocker, B.L.; Seeberger, P.H. Total synthesis of phosphatidylinositol mannosides of Mycobacterium tuberculosis. J. Am. Chem. Soc. 2006, 128, 3638-3648.
67. Elie, C.J.J.; Dreef, C.E.; Verduyn, R.; Van DerMarel, G.A.; Van Boom, J.H. Synthesis of 1-O-(1,2-Di-O-palmitoyl-SN-glycero-3-phosphoryl)-2-O-[alpha]- Dmannopyranosyl- D-myo-inositol: A fragment of mycobacterial phospholipids. Tetrahedron 1989, 45, 3477-3486.
68. Elie, C.J.J.; Verduyn, R.; Dreef, C.E.; Brounts, D.M.; van der Marel, G.A.; van Boom, J.H. Synthesis of 6-0-([alpha]-D-mannopyranosyl)-D-myo-inositol: A fragment from mycobacteria phospholipids. Tetrahedron 1990, 46, 8243-8254.
69. Watanabe, Y.; Yamamoto, T.; Ozaki, S. Regiospecific synthesis of 2,6-di-O- (a-dmannopyranosyl) phosphatidyl-d-myo-inositol. J. Org. Chem. 1996, 61, 14-15.
70. Watanabe, Y.; Yamamoto, T.; Okazaki, T. Synthesis of 2,6-di-O-[alpha]- Dmannopyranosylphosphatidyl- D-myo-inositol. Utilization of glycosylation and phosphorylation based on phosphite chemistry. Tetrahedron 1997, 53, 903-918.
71. Stadelmaier, A.; Biskup, M.B.; Schmidt, Richard, R. Synthesis of serine-linked phosphatidylinositol mannosides (PIMs). Eur. J. Org. Chem. 2004, 2004, 3292-3303.
72. Jayaprakash, K.N.; Lu, J.; Fraser-Reid, B. Synthesis of a key Mycobacterium tuberculosis biosynthetic phosphoinositide intermediate. Bioorg. Med. Chem. Lett. 2004, 14, 3815-3819. (Pubitemid 38760086)
73. Guerin,M.E.; Kordulakova, J.; Alzari, P.M.; Brennan, P.J.; Jackson,M.Molecular basis of phosphatidyl-myo-inositol mannoside biosynthesis and regulation in mycobacteria. J. Biol. Chem. 2010, 285, 33577-33583.
74. Sayers, I.; Severn, W.; Scanga, C.B.; Hudson, J.; Le Gros, G.; Harper, J.L. Suppression of allergic airway disease using mycobacterial lipoglycans. J. Allergy Clin. Immunol. 2004, 114, 302-309. (Pubitemid 39119028)
75. Ainge, G.D.; Hudson, J.; Larsen, D.S.; Painter, G.F.; Gill, G.S.; Harper, J.L. Phosphatidylinositol mannosides: Synthesis and suppression of allergic airway disease. Bioorg. Med. Chem. 2006, 14, 5632-5642. (Pubitemid 43994476)
76. Doz, E.; Rose, S.; Nigou, J.; Gilleron, M.; Puzo, G.; Erard, F.; Ryffel, B.; Quesniaux, V.F. Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of proinflammatory cytokines by mycobacterial lipomannan. J. Biol. Chem. 2007, 282, 26014-26025. (Pubitemid 47443801)
77. Geijtenbeek, T.B.; Van Vliet, S.J.; Koppel, E.A.; Sanchez-Hernandez, M.; Vandenbroucke-Grauls, C.M.; Appelmelk, B.; Van Kooyk, Y. Mycobacteria target DCSIGN to suppress dendritic cell function. J. Exp. Med. 2003, 197, 7-17. (Pubitemid 36110253)
78. Nigou, J.; Zelle-Rieser, C.; Gilleron, M.; Thurnher, M.; Puzo, G. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: Evidence for a negative signal delivered through the mannose receptor. J. Immunol. 2001, 166, 7477-7485. (Pubitemid 32525626)
79. Tailleux, L.; Schwartz, O.; Herrmann, J.L.; Pivert, E.; Jackson, M.; Amara, A.; Legres, L.; Dreher, D.; Nicod, L.P.; Gluckman, J.C.; Lagrange, P.H.; Gicquel, B.; Neyrolles, O. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J. Exp. Med. 2003, 197, 121-127. (Pubitemid 36110263)
80. Torrelles, J.B.; Azad, A.K.; Schlesinger, L.S. Fine discrimination in the recognition of individual species of phosphatidyl-myo-inositol mannosides from Mycobacterium tuberculosis by C-type lectin pattern recognition receptors. J. Immunol. 2006, 177, 1805-1816. (Pubitemid 44092518)
81. Pitarque, S.; Herrmann, J.L.; Duteyrat, J.L.; Jackson, M.; Stewart, G.R.; Lecointe, F.; Payre, B.; Schwartz, O.; Young, D.B.; Marchal, G.; Lagrange, P.H.; Puzo, G.; Gicquel, B.; Nigou, J.; Neyrolles, O. Deciphering the molecular bases of Mycobacterium tuberculosis binding to the lectin DC-SIGN reveals an underestimated complexity. Biochem. J. 2005, 392, 615-624. (Pubitemid 43022742)
82. Maeda, N.; Nigou, J.; Herrmann, J.L.; Jackson, M.; Amara, A.; Lagrange, P.H.; Puzo, G.; Gicquel, B.; Neyrolles, O. The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan. J. Biol. Chem. 2003, 278, 5513-5516. (Pubitemid 36800791)
83. Hsu, K.-L.; Mahal, L.K. A lectin microarray approach for the rapid analysis of bacterial glycans. Nat. Protocols 2006, 1, 543-549.
84. Horlacher, T.; Seeberger, P.H. Carbohydrate arrays as tools for research and diagnostics. Chem. Soc. Rev. 2008, 37, 1414-1422.
85. Cecioni, S.; Oerthel, V.; Iehl, J.; Holler, M.; Goyard, D.; Praly, J.P.; Imberty, A.; Nierengarten, J.F.; Vidal, S. Synthesis of dodecavalent fullerene-based glycoclusters and evaluation of their binding properties towards a bacterial lectin. Chem. Eur. J. 2011, 17, 3252-3261.
86. Dai, Z.; Kawde, A.-N.; Xiang, Y.; La Belle, J.T.; Gerlach, J.; Bhavanandan, V.P.; Joshi, L.; Wang, J. Nanoparticle-based sensing of glycan-lectin interactions. J. Am. Chem. Soc. 2006, 128, 10018-10019. (Pubitemid 44201077)
87. Pei, Y.; Yu, H.; Pei, Z.; Theurer, M.; Ammer, C.; Andŕe, S.; Gabius, H.-J.; Yan, M.; Ramstr̈om, O. Photoderivatized polymer thin films at quartz crystal microbalance surfaces: Sensors for carbohydrate-protein interactions. Anal. Chem. 2007, 79, 6897-6902. (Pubitemid 47438666)
88. Kikkeri, R.; Kamena, F.; Gupta, T.; Hossain, L.H.; Boonyarattanakalin, S.; Gorodyska, G.; Beurer, E.; Coullerez, G.; Textor, M.; Seeberger, P.H. Ru(II) glycodendrimers as probes to study lectin-carbohydrate interactions and electrochemically measure monosaccharide and oligosaccharide concentrations. Langmuir 2010, 26, 1520-1523.
89. Gilleron, M.; Nigou, J.; Nicolle, D.; Quesniaux, V.; Puzo, G. The acylation state of Mycobacterial lipomannans modulates innate immunity response through Toll-like receptor 2. Chem. Biol. 2006, 13, 39-47. (Pubitemid 43099923)
90. Driessen, N.N.; Ummels, R.; Maaskant, J.J.; Gurcha, S.S.; Besra, G.S.; Ainge, G.D.; Larsen, D.S.; Painter, G.F.; Vandenbroucke-Grauls, C.M.; Geurtsen, J.; Appelmelk, B.J. Role of phosphatidylinositol mannosides in the interaction between mycobacteria and DC-SIGN. Infect. Immun. 2009, 77, 4538-4547.
91. Appelmelk, B.J.; den Dunnen, J.; Driessen, N.N.; Ummels, R.; Pak, M.; Nigou, J.; Larrouy-Maumus, G.; Gurcha, S.S.; Movahedzadeh, F.; Geurtsen, J.; Brown, E.J.; Eysink Smeets, M.M.; Besra, G.S.; Willemsen, P.T.; Lowary, T.L.; van Kooyk, Y.; Maaskant, J.J.; Stoker, N.G.; van der Ley, P.; Puzo, G.; Vandenbroucke-Grauls, C.M.; Wieland, C.W.; van der Poll, T.; Geijtenbeek, T.B.; van der Sar, A.M.; Bitter,W. The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacteriumhost interaction. Cell Microbiol. 2008, 10, 930-944. (Pubitemid 351386948)
92. Fischer, K.; Scotet, E.; Niemeyer, M.; Koebernick, H.; Zerrahn, J.; Maillet, S.; Hurwitz, R.; Kursar, M.; Bonneville, M.; Kaufmann, S.H.; Schaible, U.E. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc. Natl. Acad. Sci. U S A 2004, 101, 10685-10690. (Pubitemid 38955803)
93. Ainge, G.D.; Parlane, N.A.; Denis, M.; Hayman, C.M.; Larsen, D.S.; Painter, G.F. Phosphatidylinositol mannosides: Synthesis and adjuvant properties of phosphatidylinositol di- and tetramannosides. Bioorg. Med. Chem. 2006, 14, 7615-7624. (Pubitemid 44486790)
94. Chatterjee, D.; Hunter, S.W.; McNeil, M.; Brennan, P.J. Lipoarabinomannan. Multiglycosylated form of the mycobacterial mannosylphosphatidylinositols. J. Biol. Chem. 1992, 267, 6228-6233.
95. Chatterjee, D.; Bozic, C.M.; McNeil, M.; Brennan, P.J. Structural features of the arabinan component of the lipoarabinomannan of Mycobacterium tuberculosis. J. Biol. Chem. 1991, 266, 9652-9660. (Pubitemid 21906706)
96. Jayaprakash, K.N.; Lu, J.; Fraser-Reid, B. Synthesis of a lipomannan component of the cell-wall complex of Mycobacterium tuberculosis is based on Paulsen's concept of donor/acceptor match. Angew. Chem. Int. Ed. 2005, 44, 5894-5898. (Pubitemid 41316866)
97. Fraser-Reid, B.; Chaudhuri, S.R.; Jayaprakash, K.N.; Lu, J.; Ramamurty, C.V. Efficient chemical synthesis of a dodecasaccharidyl lipomannan component of mycobacterial lipoarabinomannan. J. Org. Chem. 2008, 73, 9732-9743.
98. Yongyat, C.; Ruchirawat, S.; Boonyarattanakalin, S. Polymerization of mannosyl tricyclic orthoesters for the synthesis of alpha(1-6) mannopyranan-the backbone of lipomannan. Bioorg. Med. Chem. 2010, 18, 3726-3734.
99. Liu, X.; Wada, R.; Boonyarattanakalin, S.; Castagner, B.; Seeberger, P.H. Automated synthesis of lipomannan backbone alpha(1-6) oligomannoside via glycosyl phosphates: glycosyl tricyclic orthoesters revisited. Chem. Commun. (Camb.) 2008, 3510-3512.
100. Plante, O.J.; Palmacci, E.R.; Seeberger, P.H. Automated solid-phase synthesis of oligosaccharides. Science 2001, 291, 1523-1527. (Pubitemid 32179214)
101. Seeberger, P.H.; Werz, D.B. Automated synthesis of oligosaccharides as a basis for drug discovery. Nat. Rev. Drug. Discov. 2005, 4, 751-763. (Pubitemid 43090496)
102. Goren, M.B.; Brokl, O.; Schaefer, W.B. Lipids of putative relevance to virulence in Mycobacterium tuberculosis: Correlation of virulence with elaboration of sulfatides and strongly acidic lipids. Infect. Immun. 1974, 9, 142-149.
103. Gilleron, M.; Stenger, S.; Mazorra, Z.;Wittke, F.;Mariotti, S.; Bohmer, G.; Prandi, J.; Mori, L.; Puzo, G.; De Libero, G. Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis. J. Exp. Med. 2004, 199, 649-659. (Pubitemid 38316432)
104. Leigh, C.D.; Bertozzi, C.R. Synthetic studies toward Mycobacterium tuberculosis sulfolipid-I. J. Org. Chem. 2008, 73, 1008-1017. (Pubitemid 351198745)
105. George, K.M.; Chatterjee, D.; Gunawardana, G.; Welty, D.; Hayman, J.; Lee, R.; Small, P.L. Mycolactone: A polyketide toxin from Mycobacterium ulcerans required for virulence. Science 1999, 283, 854-857.
106. Demangel, C.; Stinear, T.P.; Cole, S.T. Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans. Nat. Rev. Microbiol. 2009, 7, 50-60.
107. Ko, K.S.; Alexander, M.D.; Fontaine, S.D.; Biggs-Houck, J.E.; La Clair, J.J.; Burkart, M.D. Synthetic studies on the mycolactone core. Org. Biomol. Chem. 2010, 8, 5159-5165.
108. Alexander, M.D.; Fontaine, S.D.; La Clair, J.J.; Dipasquale, A.G.; Rheingold, A.L.; Burkart, M.D. Synthesis of the mycolactone core by ring-closing metathesis. Chem. Commun. (Camb.) 2006, 4602-4604. (Pubitemid 44684553)
109. Jackson, K.L.; Li, W.; Chen, C.L.; Kishi, Y. Scalable and efficient synthesis of the mycolactone core. Tetrahedron 2010, 66, 2263-2272.
110. Scharf, L.; Li, N.S.; Hawk, A.J.; Garzon, D.; Zhang, T.; Fox, L.M.; Kazen, A.R.; Shah, S.; Haddadian, E.J.; Gumperz, J.E.; Saghatelian, A.; Faraldo-Gomez, J.D.; Meredith, S.C.; Piccirilli, J.A.; Adams, E.J. The 2.5 a structure of CD1c in complex with a mycobacterial lipid reveals an open groove ideally suited for diverse antigen presentation. Immunity 2010, 33, 853-862.
111. van Summeren, R.P.; Moody, D.B.; Feringa, B.L.; Minnaard, A.J. Total synthesis of enantiopure beta-D-mannosyl phosphomycoketides from Mycobacterium tuberculosis. J. Am. Chem. Soc. 2006, 128, 4546-4547.